½ÃÀ庸°í¼­
»óǰÄÚµå
1608888

Çö󽺹̵å Á¤Á¦ ½ÃÀå : Á¦Ç° ¹× ¼­ºñ½ºº°, µî±Þº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Plasmid Purification Market, By Product & Service (Products and Services), By Grade, By Application, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Çö󽺹̵å Á¤Á¦ ½ÃÀåÀº 2024³â 19¾ï 8,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç 2031³â¿¡´Â 42¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024³âºÎÅÍ 2031³â±îÁö ¿¬Æò±Õ 11.4%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2023³â 2024³â ½ÃÀå ±Ô¸ð 19¾ï 8,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2019-2023³â ¿¹Ãø ±â°£ 2024-2031³â
¿¹Ãø ±â°£ 2024-2031³â CAGR: 11.40% 2031³â ±Ý¾× Àü¸Á 42¾ï 1,000¸¸ ´Þ·¯
±×¸² : Çö󽺹̵å Á¤Á¦ ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2024³â
Plasmid Purification Market- IMG1

Çö󽺹̵å Á¤Á¦´Â ¹ÚÅ׸®¾Æ ¼¼Æ÷¿¡¼­ Çö󽺹̵å DNA¸¦ ºÐ¸®ÇÏ´Â ±â¼úÀÔ´Ï´Ù. ¹ÚÅ׸®¾ÆÀÇ Çö󽺹̵å´Â ¿°»öü¿Ü DNA ºÐÀÚ·Î ¿°»öü DNA¿Í µ¶¸³ÀûÀ¸·Î º¹Á¦ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀϹÝÀûÀ¸·Î À¯Àü°øÇÐÀÇ º¹Á¦ º¤ÅÍ·Î »ç¿ëµË´Ï´Ù. »ýÀÇÇÐ, ³ó¾÷, ¿¡³ÊÁö µî ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ ºÐÀÚ»ý¹°ÇÐ ¿¬±¸¿Í À¯Àü°øÇÐÀÇ ÀÀ¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó °í¼øµµ Çö󽺹̵å DNA¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Çö󽺹̵å Á¤Á¦ ½ÃÀåÀº °í¼øµµ Çö󽺹̵å Á¦Á¶¿¡ ´ëÇÑ ¼ö¿ä¸¦ Àû½Ã¿¡ ºñ¿ë È¿À²ÀûÀ¸·Î ´ëÀÀÇÒ ¼ö ÀÖ´Â Áß¿äÇÑ ºÐ¾ß·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

´Ù¾çÇÑ ÃÖÁ¾ »ç¿ë »ê¾÷¿¡¼­ À¯Àü°øÇÐ ¹× ºÐÀÚ»ý¹°ÇÐ ±â¼úÀÇ ÃÖÁ¾ »ç¿ë Áõ°¡´Â Çö󽺹̵å Á¤Á¦ ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ¿äÀÎÀÔ´Ï´Ù. ÀçÁ¶ÇÕ DNA ±â¼úÀÇ ¹ßÀü°ú ½Å¾à °³¹ß ¹× ¾à¹° °³¹ßÀÇ È°¹ßÇÑ ¿¬±¸°³¹ß Ȱµ¿Àº Çö󽺹̵å DNA¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ±×·¯³ª ´Ù¿î½ºÆ®¸² ó¸® Àåºñ¿Í °ü·ÃµÈ ³ôÀº ºñ¿ë°ú À¯ÀüÀÚ º¯ÇüÀÛ¹°(GMO) °ü·Ã ±ÔÁ¦ ¹®Á¦°¡ ½ÃÀå È®´ë¿¡ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÚµ¿È­¿Í ·Îº¿ÀÇ µµÀÔÀº ´õ ³ôÀº 󸮷®°ú ÀçÇö¼º ÀÖ´Â Çö󽺹̵å Á¤Á¦¸¦ °¡´ÉÇϰÔÇÔÀ¸·Î½á »õ·Î¿î ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. Á¤È®Çϰí È®Àå °¡´ÉÇÑ Á¤Á¦ ¹æ¹ýÀÇ °³¹ßÀº À¯ÀüÀÚ º¯Çü ÀÛ¹°ÀÇ ¾ÈÀü¼º ¹®Á¦¸¦ ¾î´À Á¤µµ ÇØ°áÇÒ ¼ö ÀÖ½À´Ï´Ù.

º» ¿¬±¸ÀÇ ÁÖ¿ä Æ¯Â¡

ÀÌ º¸°í¼­´Â ¼¼°è Çö󽺹̵å Á¤Á¦ ½ÃÀåÀ» ½ÉÃþ ºÐ¼®Çϰí 2023³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2024-2031³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í CAGRÀ» Á¦°øÇÕ´Ï´Ù.

¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ Ã¢Ãâ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °í·Á»çÇ×µµ Á¦°øÇÕ´Ï´Ù.

¼¼°è Çö󽺹̵å Á¤Á¦ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ½ÇÀû, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±âÁØÀ¸·Î Á¤¸®Çß½À´Ï´Ù.

ÀÌ Á¶»çÀÇ ÁÖ¿ä ±â¾÷À¸·Î´Â Merck KGaA, QIAGEN, Thermo Fisher Scientific, Inc., Takara Bio, Promega Corporation, Zymo Research, MP BIOMEDICALS, New England Biolabs, MCLAB, Agilent Technologies Inc., Illumina Inc., Applied Biological Materials Inc. µîÀÌ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ» °ÍÀÔ´Ï´Ù.

¼¼°è Çö󽺹̵å Á¤Á¦ ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è Çö󽺹̵å Á¤Á¦ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ºÐ¼® ¸ñÀû°ú °¡Á¤

  • ºÐ¼® ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ¿ªÇС¤±ÔÁ¦¡¤µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
  • ¿µÇ⠺м®
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° ¹ß¸Å/½ÂÀÎ
  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ±â¾÷ ÀμöÇÕº´(M&A) ½Ã³ª¸®¿À
  • ½ÃÀå µ¿Çâ

Á¦4Àå ¼¼°èÀÇ Çö󽺹̵å Á¤Á¦ ½ÃÀå : Á¦Ç° ¹× ¼­ºñ½ºº°, 2019-2031³â(10¾ï ´Þ·¯)

  • Á¦Ç°
  • ¼­ºñ½º

Á¦5Àå ¼¼°èÀÇ Çö󽺹̵å Á¤Á¦ ½ÃÀå : µî±Þº°, 2019-2031³â(10¾ï ´Þ·¯)

  • ºÐÀÚ µî±Þ
  • Æ®·£½ºÆå¼Ç µî±Þ

Á¦6Àå ¼¼°èÀÇ Çö󽺹̵å Á¤Á¦ ½ÃÀå : ¿ëµµº°, 2019-2031³â(10¾ï ´Þ·¯)

  • Ŭ·Î´×°ú ´Ü¹éÁú ¹ßÇö
  • Æ®·£½ºÆå¼Ç°ú À¯ÀüÀÚ ÆíÁý
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ Çö󽺹̵å Á¤Á¦ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, 2019-2031³â(10¾ï ´Þ·¯)

  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • Çмú¿¬±¸±â°ü
  • CRO(ÀǾàǰ ÀÓ»ó½ÃÇè¼öʱâ°ü)

Á¦8Àå ¼¼°èÀÇ Çö󽺹̵å Á¤Á¦ ½ÃÀå : Áö¿ªº°, 2019-2031³â(10¾ï ´Þ·¯)

  • ºÏ¹Ì
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • Merck KGaA
  • QIAGEN
  • Thermo Fisher Scientific, Inc.
  • Takara Bio
  • Promega Corporation
  • Zymo Research
  • MP BIOMEDICALS
  • New England Biolabs
  • MCLAB
  • Agilent Technologies Inc.
  • Illumina Inc.
  • Applied Biological Materials Inc.

Á¦10Àå ¾Ö³Î¸®½ºÆ®ÀÇ Á¦¾È

  • Wheel of Fortune
  • ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
  • Coherent Opportunity Map(COM)

Á¦11Àå Âü°í¹®Çå°ú Á¶»ç ¹æ¹ý

  • Âü°í¹®Çå
  • ºÐ¼® ¹æ¹ý
  • Coherent Market Insights¿¡ ´ëÇØ
ksm 24.12.24

The plasmid purification market is estimated to be valued at USD 1.98 Billion in 2024 and is expected to reach USD 4.21 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 11.4% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: 1.98 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 11.40% 2031 Value Projection: 4.21 Bn
Figure. Plasmid Purification Market Share (%), By Region 2024
Plasmid Purification Market - IMG1

Plasmid purification is a technique of isolating plasmid DNA from bacterial cells. Bacterial plasmids are extrachromosomal DNA molecules that can replicate independently of the chromosomal DNA. They are commonly used as cloning vectors for genetic engineering purposes. With the rise in molecular biology research and application of genetic engineering across diverse fields like biomedicine, agriculture, energy, and others, the demand for highly pure plasmid DNA has increased tremendously. Plasmid purification market has emerged as an important segment to address the need for pure plasmid preparations in a timely and cost-effective manner.

Market Dynamics:

Increasing application of genetic engineering and molecular biology techniques across various end-use industries is a major growth driver for the plasmid purification market. Advancements in recombinant DNA technology and proliferating R&D activities in drug discovery and development have augmented the demand for plasmid DNA. However, high costs associated with downstream processing equipment and regulatory issues pertaining to genetically modified organisms (GMOs) are hindering the market expansion. Adoption of automation and robotics provide new opportunities by enabling higher throughput and reproducible purification of plasmids. Development of precise and scalable purification methodologies can help address safety concerns around GMOs to some extent.

Key Features of the Study:

This report provides in-depth analysis of the global plasmid purification market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global plasmid purification market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Merck KGaA, QIAGEN, Thermo Fisher Scientific, Inc., Takara Bio, Promega Corporation, Zymo Research, MP BIOMEDICALS, New England Biolabs, MCLAB, Agilent Technologies Inc., Illumina Inc., and Applied Biological Materials Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global plasmid purification market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global plasmid purification market

Market Segmentation

  • Product & Service Insights (Revenue, USD Bn, 2019 - 2031)
    • Products
    • Instruments
    • Kits & Reagents
    • Services
  • Grade Insights (Revenue, USD Bn, 2019 - 2031)
    • Molecule Grade
    • Transfection Grade
  • Application Insights (Revenue, USD Bn, 2019 - 2031)
    • Cloning & Protein Expression
    • Transfection & Gene Editing
    • Others
  • End User Insights (Revenue, USD Bn, 2019 - 2031)
    • Pharmaceutical & Biotechnology Companies
    • Academic & Research Institutes
    • Contract Research Organizations
  • Regional Insights (Revenue, USD Bn, 2019 - 2031)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Merck KGaA
    • QIAGEN
    • Thermo Fisher Scientific, Inc.
    • Takara Bio
    • Promega Corporation
    • Zymo Research
    • MP BIOMEDICALS
    • New England Biolabs
    • MCLAB
    • Agilent Technologies Inc.
    • Illumina Inc.
    • Applied Biological Materials Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Plasmid Purification Market, By Product & Service
    • Plasmid Purification Market, By Grade
    • Plasmid Purification Market, By Application
    • Plasmid Purification Market, By End User
    • Plasmid Purification Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Market Trends

4. Global Plasmid Purification Market, By Product & Service, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
    • Instruments
    • Kits & Reagents
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Plasmid Purification Market, By Grade, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Molecule Grade
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Transfection Grade
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Plasmid Purification Market, By Application, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Cloning & Protein Expression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Transfection & Gene Editing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Plasmid Purification Market, By End User, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Pharmaceutical & Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Contract Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Plasmid Purification Market, By Region, 2019 - 2031, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Grade, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Grade, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Grade, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Grade, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Grade, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Grade, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • QIAGEN
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Takara Bio
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Promega Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Zymo Research
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • MP BIOMEDICALS
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • New England Biolabs
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • MCLAB
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Illumina Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Applied Biological Materials Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦